{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:51:44Z","timestamp":1790095904389,"version":"4.0.1"},"reference-count":21,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"French Ministry of Health","award":["PHRC 2018 API 18-0191"],"award-info":[{"award-number":["PHRC 2018 API 18-0191"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2020,8]]},"abstract":"\n Introduction<\/jats:title>\n Hyperkalaemia is a common electrolyte disorder and can be life-threatening. In the emergency room (ER), interventions aim to protect patients from the immediate dangers of elevated serum potassium by redistributing potassium ions from the bloodstream into the cells via intravenous insulin or nebulised beta2-agonists. However, to date, evidence for acute management of hyperkalaemia is limited. The aim of this randomised controlled trial is therefore to compare three strategies, namely insulin\/glucose intravenous infusion, nebulised salbutamol or a combination of nebulised salbutamol and insulin\/glucose intravenous infusion to reduce serum potassium concentration at 60\u2009min as a first-line treatment in patients admitted to the ER with serum potassium concentrations superior or equal to 6\u2009mmol\/L.<\/jats:p>\n <\/jats:sec>\n \n Methods and analysis<\/jats:title>\n INSAKA is a prospective, multicentre, controlled, open-label, parallel-group, randomised in a 1:1:1 ratio clinical trial. Patients will be eligible for randomisation if they have serum potassium concentrations superior or equal to 6\u2009mmol\/L measured in the ER. Patients will receive either: (1) 10\u2009mg of nebulised salbutamol, (2) 10 units of short-acting insulin in an intravenous bolus with 500\u2009mL of 10% glucose or (3) 10 units of short-acting insulin in an intravenous bolus with 500\u2009mL of 10% glucose combined with 10\u2009mg of nebulised salbutamol. The primary endpoint will be the mean change in the absolute serum potassium level from baseline to 60\u2009min measured in mmol\/L. We plan to include 525 patients.<\/jats:p>\n <\/jats:sec>\n \n Ethics and dissemination<\/jats:title>\n The INSAKA trial will be conducted in accordance with the International Council on Harmonization Good Clinical Practices. All trial documents and procedures have been reviewed and approved by the Ethics Committee Sud M\u00e9diterran\u00e9e III (approval ID number: 19.07.16.36428). The results will be actively disseminated through peer-reviewed journals, conference presentations, social media, broadcast media, print media and the internet.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n \n EudraCT number: 2019-002710-39, Clinicaltrials.gov identifier:\n NCT04012138<\/jats:ext-link>\n .\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-039277","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T02:15:43Z","timestamp":1598494543000},"page":"e039277","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Insulin glucose infusion versus nebulised salbutamol versus combination of salbutamol and insulin glucose in acute hyperkalaemia in the emergency room: protocol for a randomised, multicentre, controlled study (INSAKA)"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct04012138","registry":"10.18810\/clinical-trials-gov","type":"preResults"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2313-1172","authenticated-orcid":false,"given":"Emmanuel","family":"Montassier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Benoit","family":"Hardouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"2020082700401967000_10.8.e039277.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002011","article-title":"Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission","volume":"2","author":"Fleet","year":"2012","journal-title":"BMJ Open"},{"key":"2020082700401967000_10.8.e039277.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.09.039"},{"key":"2020082700401967000_10.8.e039277.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.030576"},{"key":"2020082700401967000_10.8.e039277.4","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.132"},{"key":"2020082700401967000_10.8.e039277.5","doi-asserted-by":"publisher","DOI":"10.1186\/cc11872"},{"key":"2020082700401967000_10.8.e039277.6","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-019-0509-8","article-title":"Management of hyperkalemia in the acutely ill patient","volume":"9","author":"D\u00e9pret","year":"2019","journal-title":"Ann Intensive Care"},{"key":"2020082700401967000_10.8.e039277.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.01.367"},{"key":"2020082700401967000_10.8.e039277.8","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.ejim.2013.02.010","article-title":"Hyperkalemia in the emergency department: etiology, symptoms and outcome of a life threatening electrolyte disorder","volume":"24","author":"Pfortm\u00fcller","year":"2013","journal-title":"Eur J Intern Med"},{"key":"2020082700401967000_10.8.e039277.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03818.x"},{"key":"2020082700401967000_10.8.e039277.10","first-page":"283","article-title":"Hyperkalemia","volume":"73","author":"Hollander-Rodriguez","year":"2006","journal-title":"Am Fam Physician"},{"key":"2020082700401967000_10.8.e039277.11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJM198901053200113","article-title":"Preferred therapy of hyperkalemia in renal insufficiency: survey of nephrology training-program directors","volume":"320","author":"Iqbal","year":"1989","journal-title":"N Engl J Med"},{"key":"2020082700401967000_10.8.e039277.12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jemermed.2018.09.007","article-title":"Real world evidence for treatment of hyperkalemia in the emergency department (REVEAL-ED): a multicenter, prospective, observational study","volume":"55","author":"Peacock","year":"2018","journal-title":"J Emerg Med"},{"key":"2020082700401967000_10.8.e039277.13","article-title":"Emergency interventions for hyperkalaemia","volume":"2","author":"Mahoney","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2020082700401967000_10.8.e039277.14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.kint.2019.09.018","article-title":"Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"97","author":"Clase","year":"2020","journal-title":"Kidney Int"},{"key":"2020082700401967000_10.8.e039277.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2010.08.015"},{"key":"2020082700401967000_10.8.e039277.16","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-11-32"},{"key":"2020082700401967000_10.8.e039277.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.12.018"},{"key":"2020082700401967000_10.8.e039277.18","first-page":"503","article-title":"Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches","volume":"74","author":"Ngugi","year":"1997","journal-title":"East Afr Med J"},{"key":"2020082700401967000_10.8.e039277.19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.kint.2015.11.018","article-title":"Treatment of hyperkalemia: something old, something new","volume":"89","author":"Sterns","year":"2016","journal-title":"Kidney Int"},{"key":"2020082700401967000_10.8.e039277.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154963","article-title":"Optimal dose and method of administration of intravenous insulin in the management of emergency hyperkalemia: a systematic review","volume":"11","author":"Harel","year":"2016","journal-title":"PLoS One"},{"key":"2020082700401967000_10.8.e039277.21","doi-asserted-by":"crossref","unstructured":"Batterink J , Cessford TA , Taylor RAI . Pharmacological interventions for the acute management of hyperkalaemia in adults. Cochrane Database of Systematic Reviews 2015.","DOI":"10.1002\/14651858.CD010344.pub2"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-039277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T12:24:06Z","timestamp":1601036646000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-039277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8,26]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1136\/bmjopen-2020-039277"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-039277","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}